Zhongke Jiufeng Medical

【Who We Are】
Jiufeng Medical, founded in 2015 by Mr. Wu Wenhui, former President of Siemens Healthineers Northeast Asia, is an intelligent medical technology company integrating medical imaging artificial intelligence (AI) and big data cloud services, including the Nanchang Management Headquarters, Nanchang Telemedicine Diagnosis Center, Nanjing Imaging Expert Center, and Nanjing Artificial Intelligence R&D Center.
Through cutting-edge artificial intelligence technology and remote interconnection technology, with medical imaging as the entry point, Jiufeng has entered over a thousand township medical and health institutions nationwide, covering nearly 30 million rural population, with business services exceeding 4 million times.
【Our Honors】
Jiufeng Medical possesses multiple technological innovation platforms and is a Chinese Academy of Sciences Academician Workstation, Chinese Academy of Sciences (Nanchang) Mobile Medical Imaging Research Institute, Chinese Academy of Engineering Academician Workstation, and National Telemedicine Demonstration Base.
Won the championship in the 2018 Stanford MURA International Competition
Won the championship in the 2019 CheXpert International Competition
Awarded the 2019 China Great Health Industry Integrity Demonstration Enterprise
Awarded the 2019 National Science and Technology Major Project
Successfully entered the national "Project 03" in 2020
Awarded the 2020 Jiangxi Province "Specialized, Refined, Distinctive, and Innovative" Enterprise
Awarded the 2020 Top Ten Technological Innovation Enterprises
Successfully selected for the Xinhua News Agency National Brand Project in 2021
Entered the list of 5G+ Medical Health Application Pilot Projects of the Ministry of Industry and Information Technology and the National Health Commission in 2021
Selected for the National "13th Five-Year Plan" Science and Technology Innovation Achievement Exhibition in 2021
2021 Jiufeng Telemedicine Imaging Diagnosis Center
【Where We Start From】
Founder Mr. Wu Wenhui, former President of Siemens Healthineers Northeast Asia (Greater China + Korea), was named one of "China's Top 40 Business Elites Under 40" by Global Entrepreneur Magazine; holds a Master's degree in CAD/CAM from Northwestern Polytechnical University, an EMBA from China Europe International Business School, and is a Visiting Professor at Northwestern Polytechnical University; a representative figure of the first Jiangxi Province Entrepreneurship; the first * representative figure of Jiangxi Province Entrepreneurship, and Chairman of the Nanchang National High-tech Zone Biomedical Industry Association.
We are committed to empowering grassroots hospitals with world-leading artificial intelligence and interconnection technologies, providing high-quality, low-cost, wide-coverage, and high-efficiency diagnostic technologies and services, and changing the health destiny of 4 billion grassroots people worldwide.
【What Our Products Are】
Our products are "AI + Big Data + Cloud + Imaging Diagnosis", including but not limited to: Tuberculosis Imaging AI Intelligent Screening and Auxiliary Diagnosis Platform, Chest Common Disease AI Imaging Screening and Auxiliary Diagnosis System, 4G/5G Mobile Physical Examination Vehicle, Viral Pneumonia AI Screening System, Respiratory Epidemic Warning System, DR Imaging Artificial Intelligence (AI) Quality Control System, DR Imaging Smart Remote Teaching System...
【What Makes Us Special】
Jiufeng Medical has followed a path of being "both specialized and red" since its inception.
1、 "Specialized": * cutting-edge artificial intelligence
The Jiufeng Medical artificial intelligence team continuously achieves innovative breakthroughs in image algorithms, deep learning, natural language processing, and other fields. AI product applications have rapidly advanced to the forefront of the industry, winning the championship in the Stanford Global Imaging Algorithm Competition for two consecutive years in 2018 and 2019, surpassing all human imaging doctors in the competition.
The company independently developed a cloud computing-based internet microservices architecture with intellectual property rights, capable of providing 7×24 uninterrupted service and supporting high-concurrency access.
The company's tuberculosis artificial intelligence diagnostic application technology was selected for the 2019-2020 National Science and Technology Major Project.
The company continues to receive recognition from various authoritative institutions (Chinese Academy of Sciences, Grey Bird Fund, Anti-Tuberculosis Association, Xinhua News Agency National Brand Project, etc.).
2、"Red": The Jiufeng Dream and the Chinese Dream advance in parallel.
Jiufeng products bring tangible benefits to the people, win reputation for the grassroots, deliver achievements for the government, and fulfill national strategies. The Jiufeng Dream and the Chinese Dream move in the same direction, and Jiufeng's interests and pursuits are highly consistent with the interests and pursuits of the nation and the people.
Jiufeng Medical is oriented towards and empowers the grassroots, serving national key directions such as poverty alleviation, rural revitalization, hierarchical diagnosis and treatment, public health, emergency rescue, elderly care services, new infrastructure, and the Belt and Road Initiative, addressing the scarcity, imbalance, and backwardness of grassroots medical resources.
【What Our Team Culture Is Like】
Growth and customer-centricity are the common goals of the team. The company and team provide each member with space to practice their value and treat every colleague with care. We establish market and service awareness, pursue high quality and low cost, advocate innovation and learning, require efficient execution, and encourage communication and feedback.
Currently, the company is expanding rapidly and looks forward to dream-driven, goal-oriented, passionate, and learning-loving individuals joining us to work together, supporting hierarchical diagnosis and treatment and health poverty alleviation, and creating a new era of human health.